The Memory, Ageing and Cognition Centre (MACC) was established in 2010. The MACC aims to investigate and provide novel insights into the risk factors and biomarkers for cognitive decline and dementia that may lead to potential therapeutic approaches. The MACC is one of the most productive memory and dementia research study centre in Singapore, with more than 400 academic papers published. We are involved in multiple prominent international dementia clinical trials such as the Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease (the only site in Singapore), which has shown promising results. 

We imagine a future where cognitive decline and dementia can be prevented and treated. It is our mission to translate our research into productive interventions which promote healthy memory and healthy ageing in Singapore. For more information on our Studies please click here.